ATE200493T1 - Verbesserte chimäre toxine - Google Patents

Verbesserte chimäre toxine

Info

Publication number
ATE200493T1
ATE200493T1 AT91906038T AT91906038T ATE200493T1 AT E200493 T1 ATE200493 T1 AT E200493T1 AT 91906038 T AT91906038 T AT 91906038T AT 91906038 T AT91906038 T AT 91906038T AT E200493 T1 ATE200493 T1 AT E200493T1
Authority
AT
Austria
Prior art keywords
fragment
toxin
diphtheria toxin
chimeric
domain
Prior art date
Application number
AT91906038T
Other languages
English (en)
Inventor
Diane Williams
John R Murphy
Original Assignee
Boston Medical Ct Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27049417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE200493(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boston Medical Ct Corp filed Critical Boston Medical Ct Corp
Application granted granted Critical
Publication of ATE200493T1 publication Critical patent/ATE200493T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT91906038T 1990-03-02 1991-02-28 Verbesserte chimäre toxine ATE200493T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48860890A 1990-03-02 1990-03-02
US53743090A 1990-06-13 1990-06-13
PCT/US1991/001282 WO1991013090A1 (en) 1990-03-02 1991-02-28 Improved chimeric toxins

Publications (1)

Publication Number Publication Date
ATE200493T1 true ATE200493T1 (de) 2001-04-15

Family

ID=27049417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906038T ATE200493T1 (de) 1990-03-02 1991-02-28 Verbesserte chimäre toxine

Country Status (11)

Country Link
US (6) US5616482A (de)
EP (1) EP0517829B2 (de)
JP (1) JP3311346B2 (de)
AT (1) ATE200493T1 (de)
CA (1) CA2076678C (de)
DE (1) DE69132581T3 (de)
DK (1) DK0517829T4 (de)
ES (1) ES2155821T5 (de)
FI (1) FI923915A7 (de)
GR (1) GR3036081T3 (de)
WO (1) WO1991013090A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
US6737511B1 (en) * 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US20030162733A1 (en) * 2000-11-27 2003-08-28 Haynes Joel R. Nucleic acid adjuvants
US7273722B2 (en) * 2000-11-29 2007-09-25 Allergan, Inc. Neurotoxins with enhanced target specificity
EP1687016A4 (de) * 2003-11-25 2009-07-29 Anjin Corp Diphertie-toxin-variante
EP1738174A2 (de) * 2004-03-31 2007-01-03 Trophogen, Inc. Menschliche glycoproteinhormon-superagonisten und verwendungen davon
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
WO2008025074A1 (en) * 2006-08-28 2008-03-06 Clinuvel Pharmaceuticals Limited Method for reducing incidence or rate of development of skin cancers and related conditions
ES2987072T3 (es) 2006-09-07 2024-11-13 Scott & White Memorial Hospital Métodos y composiciones basados en conjugados de toxina diftérica-interleucina-3
AU2008279550B2 (en) * 2007-06-21 2012-08-09 Angelica Therapeutics, Inc. Modified toxins
WO2009110944A1 (en) * 2008-02-29 2009-09-11 Angelica Therapeutics, Inc. Modified toxins
WO2011047135A2 (en) * 2009-10-14 2011-04-21 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treating bladder cancer
EP2968450A4 (de) 2013-03-15 2016-10-26 Angelica Therapeutics Inc Modifizierte toxine
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11965009B2 (en) 2016-03-10 2024-04-23 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US11203626B2 (en) 2016-03-10 2021-12-21 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
JP2019512233A (ja) 2016-03-10 2019-05-16 ザ・ジョンズ・ホプキンス・ユニバーシティー 凝集体を含まない単量体のジフテリア毒素融合タンパク質の生成方法及び治療的使用法
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2022043863A1 (en) 2020-08-26 2022-03-03 Citius Pharmaceuticals, Inc. Combination for use in methods of treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU573529B2 (en) 1982-05-12 1988-06-16 President And Fellows Of Harvard College Hybrid proteins
US4468382A (en) † 1982-07-15 1984-08-28 New England Medical Center, Inc. Polypeptide-toxin hybrid protein
ATE68703T1 (de) * 1984-02-08 1991-11-15 Cetus Corp Toxinkonjugate.
US4830962A (en) * 1984-02-09 1989-05-16 Cetus Corporation Recombinant diphtheria toxin fragments
ES8708014A1 (es) * 1984-06-07 1987-09-01 Murphy John R Un procedimiento para preparar un gen fusionado que codifica una proteina hibrida susceptible de marcado y empleo en diagnosis.
WO1987002987A1 (en) * 1985-11-13 1987-05-21 Murphy John R Cys codon-modified dna
IN165717B (de) * 1986-08-07 1989-12-23 Battelle Memorial Institute
IL89504A0 (en) * 1988-03-08 1989-09-10 Univ Wyoming Diphtheria toxin derivative,process for the preparation thereof and pharmaceutical composition containing the same
CA2083487A1 (en) * 1990-06-13 1991-12-14 John R. Murphy Chimeric toxins with improved inter-domain geometry

Also Published As

Publication number Publication date
GR3036081T3 (en) 2001-09-28
WO1991013090A1 (en) 1991-09-05
JP3311346B2 (ja) 2002-08-05
DE69132581T2 (de) 2002-04-11
EP0517829B2 (de) 2007-12-26
FI923915L (fi) 1992-09-01
ES2155821T3 (es) 2001-06-01
AU7493191A (en) 1991-09-18
JPH06500531A (ja) 1994-01-20
US5677148A (en) 1997-10-14
US5616482A (en) 1997-04-01
AU661819B2 (en) 1995-08-10
US5763250A (en) 1998-06-09
US5932471A (en) 1999-08-03
US5703039A (en) 1997-12-30
CA2076678C (en) 1999-09-28
EP0517829B1 (de) 2001-04-11
FI923915A0 (fi) 1992-09-01
EP0517829A1 (de) 1992-12-16
ES2155821T5 (es) 2008-04-16
DK0517829T4 (da) 2008-03-03
DK0517829T3 (da) 2001-05-07
DE69132581D1 (de) 2001-05-17
DE69132581T3 (de) 2008-07-17
EP0517829A4 (en) 1993-05-05
CA2076678A1 (en) 1991-09-03
FI923915A7 (fi) 1992-09-01
US5863891A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
ATE200493T1 (de) Verbesserte chimäre toxine
NO840089L (no) Hybrid-proteiner
NO964650L (no) LAG-3 proteinopploselige polypeptidfraksjoner, fremgangsmate for fremstilling, terapeutisk preparat og anti-idiotype antistoff
ATE329033T1 (de) Hybride toxine
NZ504752A (en) Hydrophobically-modified protein compositions (particularly hedgehog proteins)
NZ212312A (en) Hybrid protein comprising fragments of diphtheria toxin and part of cell-specific ligand; and fused gene therefor
WO1999003881A3 (fr) Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
Graf et al. Cathepsin D generates γ-endorphin from β-endorphin
Fawell et al. Androgen-regulated proteins of rat seminal vesicle secretion constitute a structurally related family present in the copulatory plug
SE8204811L (sv) Dna-fragment innefattande en signalsekvens
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
FR2736916B1 (fr) Proteines hetero-multimeriques recombinantes du type alpha-beta c4bp
NO923415L (no) Forbedrede chimere toksiner
DK1355655T5 (da) Præparater og fremgangsmåder til forbedring af nyrefunktion
Greenfield et al. Toxin conjugates.
GB2333295A (en) Modified protein G and fragments thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0517829

Country of ref document: EP

EELA Cancelled due to lapse of time